Cardiology
Conference Coverage
Myeloma therapies raise cardiovascular risks
WASHINGTON – The proteasome inhibitor carfilzomib increases risk for heart failure, and thalidomide analogs increase the risk for venous...
News
Heart failure outcomes are worse in select HIV-infected individuals
Rates of 30-day HF readmission, cardiovascular mortality, and all-cause mortality are worse among individuals with a low CD4 count or...
News
Death data spur black-box warning for gout drug Uloric
FDA acts after postmarket trial shows higher all-cause and heart-related death when compared against allopurinol.
Conference Coverage
Stroke endovascular therapy: The more you do, the better you do
HONOLULU – Centers performing more endovascular thrombectomies produced better patient outcomes.
Conference Coverage
Take action to mitigate CVD risk in RA patients
The mechanisms of increased CVD risk in RA are multifactorial, and risk management strategies should take into account a patient’s apparent risk,...
Conference Coverage
SGLT2 inhibitors morph into HF drugs
“
Conference Coverage
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
Conference Coverage
Biomarkers predict VTE risk with menopausal oral hormone therapy
CHICAGO – Pretreatment high D-dimer spells 500% increased VTE risk on oral hormone therapy.
News
Statins cut vascular events in elderly patients
Analysis challenges current practice of discontinuation after age 75 years.
Conference Coverage
Medical advice prompts unneeded emergency visits by AF patients
BOSTON – Unnecessary ED visits by asymptomatic atrial fibrillation patients are often linked with prior medical advice received.